Nuzenio

Rugonersen

Rugonersen news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Tue, 28 Jul 2026 12:18:36 GMTOak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome - The Manila Times
Tue, 28 Jul 2026 07:00:00 GMTOak Hill takes SPAC track to Nasdaq with Roche asset in tow - BioSpace
Tue, 28 Jul 2026 00:00:14 GMTOak Hill to get $175M cash infusion in merger with RA Capital-backed SPAC - FirstWord PHARMA
Mon, 27 Jul 2026 19:25:29 GMTRA Capital launches Oak Hill Bio onto the Nasdaq via SPAC - Fierce Biotech
Mon, 27 Jul 2026 14:19:47 GMTRA Capital-backed Oak Hill to go public in USD 175m SPAC deal - AllSci
Mon, 27 Jul 2026 12:00:00 GMTOak Hill Bio and Research Alliance Corporation III Announce - GlobeNewswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Rugonersen.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.